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Human rhinovirus (HRV) is one of the most common human respiratory pathogens and is responsible for
the majority of upper respiratory illnesses. Recently, a phylogeny was constructed from all known Ameri-
can Type Culture Collection (ATCC) HRV sequences. From this study, three HRV classiﬁcations (HRVA,
HRVB, and HRVC) were determined and techniques for classifying new isolates of HRV were reported.
The genetic change of this virus in speciﬁc populations over time is of great interest to understand the
evolution and epidemiology of viruses. To facilitate the collections of HRV sequences over a number of
years, a virology experiment was designed in which students test nasal lavage samples to look for HRV
infection. Students will learn a variety of techniques including RNA isolation, cDNA synthesis, qPCR, and
agarose gel electrophoresis as well as bioinformatic skills though examination of sequences from the
HRV-ﬁeld isolates. Furthermore, students can look at symptom data from subjects to investigate correla-
tions between symptom severity and factors such as stress and sleep patterns. Such information can be
used to examine hypotheses regarding HRV mutation, symptom severity and epidemiology.
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INTRODUCTION
Virology is an interdisciplinary ﬁeld that incorporates
aspects of biochemistry, cell biology, molecular biology,
and immunology. Thus, the study of virology is intriguing
to students not only because of its depth but also
because of viruses that have a very visible effect on a
university population when cold and ﬂu season arrives.
Viruses are parasitic nucleic acids, either DNA or RNA,
and function through the ‘‘hijacking’’ of the host cell’s own
machinery. A productive viral infection must spread virus
to other hosts to continue the viral life cycle, and the study
of viral spread in a population is a principle concern of viral
epidemiology. Viral epidemiology not only examines how a
virus functions in the host but also opens a window into
human habits and interactions. Some viruses are transmit-
ted through aerosols, others via an oral/fecal route, and
still others through the transmission of bodily ﬂuids [1].
Thus, many viruses thrive by taking advantage of host
habits. By understanding how viruses replicate and
spread, students can gain insight into the functions of
viruses, cells, and evolution. Many viruses quickly adapt to
environmental changes through error-prone replication,
resulting in mutations and the generation of viral quasi
species in which many genotypes coexist simultaneously
during replication in the host cells. Subsequent infection in
a new host results in replication by viruses ﬁt for a particu-
lar environment [1, 2].
Human rhinovirus (HRV), a picornavirus, is a member
of the largest pathogenic virus family that includes such
members as poliovirus, coxsackie virus, hepatitis A, and
foot and mouth disease virus. Picornaviruses are positive
(mRNA-like), single-stranded RNA viruses, encased in a
30-nanometer icosahedral protein capsid. Their genomes
contain roughly 8,000 nucleotide bases that code for 12
proteins [1, 3]. HRV has a well-characterized genome
with three main classiﬁcations currently identiﬁed: HRVA,
HRVB, and HRVC. During replication, millions of viral par-
ticles are made; however, the nucleic acids are not
exactly identical. The HRV polymerase is error prone,
and so several mutations occur through each round of
replication. Thus, each viral nucleic acid can be slightly
different. These variants are referred to as viral quasi
species and enable HRV to adapt to the host [1, 2].
To date, there are 99 HRV serotypes recognized by the
American Type Tissue Culture Collection (ATCC).
although there are likely many more in the population
considering the viral quasi species phenomenon. HRV
infections occur worldwide at all times of the year, with
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strong outbreaks in the fall and late spring. However,
HRV is only one of many respiratory viruses—others,
including adenovirus and coronavirus, produce similar
symptoms [1, 3]..HRV infections are usually limited to the
upper respiratory tract, though they can also result in
acute otitis (inﬂammation of the middle ear), sinusitis
(inﬂammation of the paranasal sinuses), and lower respi-
ratory tract infections [4–6].
The extensive data available on HRV genomes enables
many bioinformatics opportunities for students, including
alignment of genome sequences to look for mutations at
the RNA level and differences among protein sequences.
Students can examine differences in the HRV serotypes
over several years of data regarding a university popula-
tion to identify HRV mutations that have occurred and
their severity in causing symptoms in the host. This inves-
tigation is not only a way for students to study virus evo-
lution but serves as an introduction in viral epidemiology.
In this inquiry-based laboratory project, students use a
variety of techniques, including RNA isolation, cDNA syn-
thesis, qPCR, and agarose gel electrophoresis to look for
the presence of HRV in nasal lavage samples from
human subjects. The samples that are shown to be posi-
tive for HRV can then be sequenced to determine the
strain of the isolate. By analyzing surveys in which sub-
jects indicate severity of their symptoms, stress factors,
and average hours of rest per night, students can identify
possible contributors to HRV infection. These factors
have been seen to make subjects more susceptible to
the common cold and other viruses that cause upper re-
spiratory infections [7–10].
LABORATORY EXERCISE
Students who participate in this exercise should have
basic biochemistry and molecular biology laboratory skills.
They should be familiar with basic laboratory equipment
(pipettors and centrifuges) and agarose gel electrophore-
sis if there is no qPCR thermocycler available to the lab.
The laboratory exercise has convenient stopping points
and can be completed in two laboratory periods if done
efﬁciently. This laboratory works well with teams of two
students who are allowed to divide the work.
Session 1
• Students collect nasal lavage samples from them-
selves and classmates and survey their symptoms—
this can be done before lab if student are equipped
with needle-less syringes and sterile tubes and
instructed in collection technique.
• Students isolate RNA from samples and synthesize
cDNA (process can be stopped after isolation, but it
is best to proceed to cDNA step if possible).
Session 2
• Students setup and perform both qPCR and PCR—
while these are running, students can analyze data
from symptom surveys.
• (Students can run an agarose gel of the PCR prod-
uct and image it.)
Session 3
• (Students can run an agarose gel of the PCR prod-
uct and image it.)
• Students prepare samples for sequencing.
(Session 4—when sequence data is returned)
• Students analyze sequences and draw conclusions
regarding differences in serotypes found and how
they differ from previous years.
Ethics and Safety
All aspects of the study involving human subjects must
be approved by the school’s institutional review board.
Subjects must be informed of the experiment and the
use of the data and must sign an approved consent form
before a sample can be obtained from them. Students in
the laboratory must be informed of the importance of an-
onymity of the samples they are testing, which should be
assigned initials of the subject or, better yet, numbers.
Students should wear gloves whenever they are handling
samples or cDNA. Special care should be taken when
using TRIzol reagent—TRIzol should be used in a chemi-
cal fume hood to avoid inhalation of vapors. Students
should wear gloves and protective eyewear, avoiding any
chemical contact with the skin or clothing.
MATERIALS AND METHODS
Nasal Lavage—Collect Mucosal Samples from a Variety of
Sick and Healthy Students
Students ﬁrst collected nasal lavage samples from them-
selves and their classmates. Subjects were informed of the
experiment and signed a consent form. Students used a 1-mL
syringe (Becton Dickinson, Franklin Lakes, NJ) to inject 1 mL of
water into the nostril of the subject by placing the tip of the sy-
ringe just inside the nostril touching the inside of the nose and
injecting the water. The water was then allowed to fall back out
of the nose and collected in a sterile 15-mL centrifuge tube
(Cellstar–Greiner Bio-one, Monroe NC) held under the nostril.
Students also asked their subjects to ﬁll out a short survey
(attached along with consent form) regarding their health, sleep
habits, and stress levels. Subjects rated symptoms associated
with the common cold on a scale of 0 to 4, with 0 being non-
existent and 4 being severe (survey included, see Supporting
Information 3).
RNA Isolation and cDNA Synthesis
Filtered pipet tips and gloves were used at all times to pre-
vent RNA degradation of the sample. From each sample, 350
lL were moved to a sterile 1.8-mL microfuge tube (Eppendorf,
Hamburg, Germany) with 25-lL 53 nucleic acid extraction
buffer (Final concentrations of components: pH7.5 Tris 500 mM,
NaCl 1500 mM, and EDTA 5 mM) (Supporting Information 2)
and 10 lL of carrier mix for RNA isolation consisting of 0.5 lL
of human DNA (100 ng/lL) (Sigma-Aldrich), 4 lL glycogen (5
lg/lL) (Applied Biosystems, Carlsbad, CA), 1 lL of glycoblue
(15 lg/lL; Applied Biosystems, Carlsbad, CA) and 4.5 lL of
phosphate buffered saline. RNA was isolated from the sample
by adding 750 lL of TRIzol LS Reagent (Invitrogen, Carlsbad,
CA), and the tubes were vortexed (Scientiﬁc Industries Inc,
Bohemia, NY) vigorously for 1 minute before 200 lL chloroform
was added. The tubes were again vortexed for 1 minute and
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then centrifuged (Eppendorf Centrifuge 5415C, Hamburg, Ger-
many) at 13,000 3 g for 10 minutes. The aqueous layer was
removed to a new Eppendorf tube containing 600 lL of RNAse-
free isopropyl alcohol. The tubes were then inverted several
times, allowed to stand for at least 5 minutes at room tempera-
ture and then centrifuged at 13,000 3 g for 10 minutes to pellet
the RNA. The supernatant was then removed and 700 lL of
75% ethanol, at room temperature, were added to the pellet.
The tubes were then centrifuged for another 5 minutes at
13,000 3 g, and the supernatant was carefully removed so as
not to disturb the pellet of RNA. Each RNA pellet was then
resuspended in 22 lL RNase-free water and vortexed vigo-
rously to dissolve the RNA.
Reverse transcription was conducted by ﬁrst placing a mix-
ture of the following reagents in each 0.5-mL Eppendorf tube: 8
lL 53 AMV-RT buffer, 8 lL 5 mM dNTP (Promega, Madison,
WI), 1.0 lL random hexamers (IDT, Coralville, IA), 0.5 lL RNase
inhibitor (Promega, Madison, WI), 0.6 lL AMV (Promega, Madi-
son, WI) reverse transcriptase, and 5.9 lL RNase-free water.
Next, 16 lL of viral RNA were added to each tube. An upscaled
master mix was prepared and apportioned for multiple samples.
Reverse transcription was performed in a thermocycler (MJ
Research, Waltham, MA) with the following program: 258C for 5
minutes, 428C for 10 minutes, 508C for 20 minutes, and 858C
for 5 minutes.
qPCR—One Method of Looking for Viral Presence in
Collected Samples
qPCR was performed on the cDNA from samples (Applied
Biosystems 7500 Real Time PCR System, Carlsbad, CA) using
FastStart Universal SYBR Green Master (ROX) mix (Roche,
Basel, Switzerland). The primers amplify 400-bp region of the
noncoding region of HRV [5]. The primer stocks were resus-
pended in water at a concentration of 200 lM each. A 150-lL
mix of the forward primer mix was made by adding 18.75 lL of
each P1-1 primer to 93.75 lL water for a ﬁnal concentration of
25 lM for each primer (Supporting Information 2). The P3-1
primer was diluted 1:8 to a ﬁnal concentration of 25 lM. A 20-
lL reaction was performed using 1 lL of cDNA, 10 lL of the
SYBR Green Master mix, 1 lL of forward primer mix, (P1-1, B1:
CAAGCACTTCTGTTTCCCC B2: CAAGCACTTCTGTTACCCC
B3: CAAGCACTTCTGTCTCCCC) and 1 lL of the reverse primer
(P3-1: ACGGACACCCAAAGTAG) (2 lM), and 7 lL of water in
0.2-mL clear-topped strip tubes (BioExpress, Kaysville, UT) [5].
An upscaled master mix was prepared and apportioned for mul-
tiple samples.
PCR and Agarose Gel Electrophoresis—Alternative Way of
Determining Presence of Virus
Two rounds of PCR ampliﬁcation were performed using (P1-
1, B1: CAAGCACTTCTGTTTCCCC B2: CAAGCACTTCTGT-
TACCCC B3: CAAGCACTTCTGTCTCCCC) forward primer mix
and P1-3 reverse primer (ACGGACACCCAAAGTAG). The primer
stocks were resuspended in water at a concentration of 200 lM
each. A 150-lL mix of the forward primer mix was made by
adding 18.75 lL of each P1-1 primer to 93.75 lL water for a
ﬁnal concentration of 25 lM for each primer. The P3-1 primer
was diluted 1:8 to a ﬁnal concentration of 25 lM. The PCR
reaction contained 22.5 lL of the PCR Platinum SuperMix High
Fidelity (Invitrogen, Carlsbad, CA) mix, 1 lL of P3-1 primer
(ACGGACACCCAAAGTAG), 0.5 lL of the P1 mix, and 2.5 lL of
cDNA for a total of 26.5 lL. The reaction was run with a touch-
down PCR according to the reaction conditions in Supporting
Information 2 [5].
This ﬁrst reaction was followed by a second PCR: The PCR
contained 45 lL of the Platinum mix, 1 lL of P3-1 primer (25
lM), 1 lL of the P1-1 (25 lM), and 3 lL of the products from
the previous PCR. The products were analyzed in the following
way: A 1.5% agarose gel was used to separate the products of
the PCR (SeaKem LE, Erie, PA; Phusion, NEB, Ipswich, MA) Hi-
Lo2 DNA maker loading dye (Promega, Madison, WI). Gels
were made with 13 Tris Borate EDTA (TBE) buffer and run at
80V (VWR Power Source 250 V, West Chester, PA). Nucleic
acids were imaged using ethidium bromide (EtBr) and a Foto-
dyne system (Hartland, WI).
Sequencing
HRV PCR products were sequenced to determine the genetic
makeup of each ﬁeld isolate. Samples were prepared by adding
4 lL of Exo-SAP-IT (USBiochemicals, Cleveland, Ohio) into 10
lL of PCR product. This mixture was incubated at 378C for 25
minutes and then 908C for 15 minutes. The resulting product
was stored at 2208C until sequencing could be performed.
Sequencing was performed by DeWalch Technologies,
(Houston, TX) using primer P3-1 (ACGGACACCCAAAGTAG; see
Supporting Information 2).
Multiple Alignment and Phylogeny
Sequences from the samples were entered into BLAST [11].
The resulting BLAST information established to which HRV
sequence from the ATCC the sample was most closely related.
A multiple sequence alignment and cladogram (using group
tree) were both generated using web-based ClustalW2 following
the instructions provided [12].
Analysis of Stress, Sleep, and Symptom Levels of Subjects
Questionnaires for determining a subject’s stress sleep and
symptom severity were adapted from previously published
studies [7, 8, 13, 14] (Supporting Information 3). Brieﬂy, stress
was assessed through a subject’s rating his or her average
stress level on a 1–5 scale with 5 being the most severe. The
quality and duration of sleep was assessed based on the
reported number of hours (1–10). The severity of symptoms was
determined by subjects rating each of their cold symptoms on
a scale of 0–4 (4 most severe) and adding the resultant scores
together to give a ﬁnal symptom score. The symptom score
was then adjusted to a 1–10 scale. A two-tailed t test was then
used to determine the signiﬁcance (GraphPad Software, Inc
http://www.graphpad.com/quickcalcs/ index.cfm).
RESULTS AND DISCUSSION
HRV Detection
The primer set used to detect HRV in the samples was
adapted from Lee et al. [5] and detects all 99 possible
ATCC serotypes through the ampliﬁcation of 400-bp
portion of the 50 noncoding region of HRV. The detection
of HRV was conducted with both conventional PCR and
qPCR using the same primer set. The qPCR method is
preferable due to increased sensitivity. Great care needs
to be taken when preparing the viral RNA from samples
to prevent degradation and loss of the RNA pellet during
the precipitation procedure.
Of the 28 samples obtained from human volunteers,
the qPCR indicated 17 were positive for HRV (Fig. 1).
The 17 positive samples showed clear differences in the
amount of viral nucleic acid present as indicated by the
differences in cycle number. These differences can be
manifest for several reasons including stage of the infec-
tion and the efﬁciency of HRV nucleic acid isolation. One
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can quantify the exact amount of virus using laboratory-
grown strains, but this approach is beyond the scope of
this article and the availability of equipment in many
undergraduate laboratories.
The standard PCR and subsequent agarose gels dem-
onstrated this technique’s weaker sensitivity compared
to the qPCR (Figs. 2a and 2b). Of the 17 positives on
qPCR, six were positive with standard PCR. Samples
with low amounts of viral nucleic acid or samples conta-
minated with RNases likely only appear as positive on
the qPCR. No samples appeared as positive in conven-
tional PCR after a negative result from qPCR.
Sequencing
There are 99 HRV serotypes recognized by the ATCC
and extensive data available on HRV genomes enables
many bioinformatics opportunities for students, including
alignment of genome sequences to look for changes at
the RNA level. Standard PCR was used to generate
enough genetic material for sequencing, and students
retrieved sequences from the service provider website
and submitted them as BLAST queries to identify to
which ATCC strain their HRV samples were most similar
[11]. The analysis revealed that two of the six samples
were variants of HRV1 with 97% of the sequence identi-
cal with the ATCC reference strain. The other samples
were identiﬁed as being similar to ATCC reference strains
HRV2, HRV16, and HRV85. The sequences were aligned
with each other and ATCC reference strains using Clus-
talW2 and a group tree cladogram was generated (Fig. 3)
[12]. From a research perspective, the sequence data is
most interesting because, as samples are sequenced
yearly, it will be possible to create a genetic database of
HRV strains found in a college-aged population and to
do further analysis on many levels. Indeed, a discussion
was initiated with the students on how the nucleotide
variations between their samples and the ATCC strains
may inﬂuence the ability of the virus to elude the immune
system, replicate or spread between hosts.
Additional avenues of investigation can include the
analysis of predicted RNA secondary and tertiary struc-
ture [6, 15] and the sequencing of the nucleic acid re-
sponsible for coding of the viral capsid or the entire ge-
nome. With this information and a free program called
VIGOR, students can identify all 12 viral proteins and per-
form bioinformatics analysis in comparison to ATCC ref-
erence strains [16]. In a sense, this laboratory is similar
to the program sponsored by Howard Hughes Medical
Institute called ‘‘Phage-Hunters’’ [17].
FIG. 1. Quantitative PCR of nasal lavage samples. qPCR
spectra indicating HRV presence in samples. Twenty-eight total
samples were run—14 of subjects who reported being sick with
common cold symptoms and 14 who reported no symptoms.
The x-axis indicates the number of qPCR cycles, and y-axis
indicates the relative ﬂuorescence units. Dashed lines are those
subject who were HRV positive but did not report being sick.
The qPCR was as described in Methods and was performed by
Lawrence University students during an undergraduate general
biology class.
FIG. 2. Standard PCR of nasal lavage samples. PCR was con-
ducted as described and products were subjected to gel elec-
trophoresis and stained with SYBR green. (a) Agarose gel indi-
cating no successful HRV standard PCR in lanes 1, 5, 9, 10.
Successful standard PCR ampliﬁcation for sequencing of qPCR
samples in lanes 2, 3, 4, and 6. Lanes 7 and 8 correspond to
HRV1 and HRV 2 positive controls, respectively. (b) Agarose gel
indicating no successful HRV standard PCR in lanes 1, 2, 3, 6,
7, 9, and 10. Successful standard PCR ampliﬁcation for
sequencing of qPCR samples in lanes 4 and 5. Lane 8 corre-
sponds to the HRV16 positive control. Standard PCR and sub-
sequent agarose electrophoresis was done as described in
Methods and was performed by Lawrence University students
during an undergraduate general biology class.
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Correlation Between Symptoms, Sleep, Stress, and
HRV Infection
Studies have shown that the severity of experimental
viral infections depends not only on the viral strain but
also on the sleep and stress levels of the individuals
involved [7–10]. In this study, 21 of the 28 students vol-
unteering samples chose to participate in the symptoms,
stress, and sleep surveys as well (Figs. 4a–4c). Only 10
of the 17 HRV positive subjects chose to participate in
the surveys while all 11 of the subjects that tested nega-
tive for HRV participated in the surveys. Of those sub-
jects negative for HRV, ﬁve were found to have reported
being sick. In this instance, other viruses are probably re-
sponsible for the observed symptoms. This laboratory
can easily be extended to include PCR primers to iden-
tify other viruses including inﬂuenza, corona virus, and
adenovirus among other possibilities [18].
The average symptom, sleep, and stress scores were
compared between HRV positive and HRV negative sub-
jects and between reported sick and healthy subjects
(Figs. 4a–4c). In our data, there are two signiﬁcant trends
as determined by an unpaired t test. First, symptom
scores correlated positively with being HRV positive (p ¼
0.15, not signiﬁcant) or sick (p ¼ 0.0001, signiﬁcant; Fig.
4a). Second, the sleep amount correlated positively with
being HRV negative (p ¼ 0.1, not signiﬁcant) or healthy
(p ¼ 0.0077, signiﬁcant; Fig. 4b). However, there was no
apparent relationship between self-reported stress level
and having HRV or being sick (Fig. 4c). A larger N value
can be achieved if this laboratory is taught over multiple
years, and data is analyzed in aggregate.
In addition to looking for correlations between symp-
toms, stress levels, amount of sleep and infection, stu-
dents can collect information regarding subject residen-
ces and activity participation. Students can group
subjects by dormitory and when the results of the
sequencing return, see whether or not different residen-
ces on campus harbor different HRV strains. However,
great care must be taken to ensure student privacy in
the data collection and encoding process.
CONCLUSIONS
The value in doing this laboratory is not only pedagogi-
cal; in teaching it yearly and sequencing to track the in-
fectious cycle of HRV, it will be possible over the years
to build a record of what serotypes of HRV are affecting
a population, with particular symptoms, at a given loca-
tion. This information can help in answering questions
such as: What types of mutation occur? What types of
HRV are prevalent? What percentage of the respiratory
infections is HRV? Who contracts HRV? How does this
correlate to sleep habits and stress levels? By creating
such a dataset, insight can be gained regarding HRV
infection and mutation in a college population.
FIG. 3. Cladogram of HRV sequences. Sequences of each sample and the ATCC sequences to which they were most similar
were aligned and a phylogeny was generated using ClustalW2. BLAST and CLUSTALW2 alignment were performed by Lawrence
University students during an undergraduate general biology class.
FIG. 4. Stress, sleep, and symptoms of study subjects. (a)
Graphical representation of symptom levels. (b) Graphical repre-
sentation of sleep levels. (c) Graphical representation of stress
levels. All data were taken and analyzed by Lawrence University
students during an undergraduate general biology class.
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Potential Student Pitfalls
RNA degradation is the single most troublesome area.
Although positive and negative samples can easily be
identiﬁed via qPCR, getting enough PCR products for
the detection by gel electrophoresis can be hampered by
RNA degradation. RNase-free reagents should be used
at all times, and gloves are a must. Furthermore, delays
in the procedure for isolating the RNA can result in deg-
radation. Often, running a third PCR can be helpful in
these situations. This extra step can be done by using 45
lL of the Platinum mix, 1 lL of P3-1 primer (25 lM), 1 lL
of the P1-1 (25 lM), and 5 lL of the products from the
previous PCR.
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